Amplyus Launches Kickstarter to Move MiniPCR into Full Production | GenomeWeb

NEW YORK (GenomeWeb) ― Cambridge, Mass.-based Amplyus has launched a Kickstarter funding campaign intended to bring its miniPCR platform into full production and "open the world of DNA science to everyone, everywhere."

The device is essentially a miniaturized, computer- or smart phone app-controlled thermocycler. The one-pound machine runs eight samples at a time using standard tubes, and is about the size of a two-inch thick, four-by-five-inch note card. It has a clear case, and the app allows users to visualize the PCR cycles as they run.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.